Analyzing salivary microRNA in endometriosis patients and their response to progestin therapy
Official title: Salivary MicroRNA in Endometriosis: Correlation With Progestin Treatment Response: A Prospective Observational Study
Run by University of Udine · NCT06414720 · Data updated 2026-11-12
This study is testing if analyzing saliva can help identify which women with endometriosis will respond well to a specific hormone treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | University of Udine Academic / other |
| Locations | 1 site (Udine, UD) |
| Status | Recruiting |
| Started | April 22, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | December 1, 2025 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06414720 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women over 18 years of age with a clinical or histological diagnosis of endometriosis who are not currently undergoing progestin therapy.
✕Probably not a fit
Patients who are pregnant, pre-menopausal, post-menopausal, or have conditions affecting salivary miRNA measurement may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the salivary microRNA profiles of patients diagnosed with endometriosis to determine differences between those who respond to progestin therapy and those who do not. Ninety patients attending the Chronic Pelvic Pain Clinic will provide saliva samples before starting treatment with 2 mg dienogest. After four months of therapy, the researchers will evaluate the treatment response and analyze the salivary miRNA signatures to identify potential biomarkers for therapy response. The goal is to enhance non-invasive diagnostic tools for early identification and treatment of endometriosis.
Why it matters
Potential benefit: If successful, this study could lead to the development of a non-invasive biomarker for predicting treatment response in endometriosis patients.
How similar studies have gone: While there has been progress in identifying biomarkers for endometriosis, this specific approach using salivary miRNA profiles is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
INCLUSION CRITERIA * Age \> 18 years * Fertile age * Clinical-ultrasound diagnosis or histological diagnosis of endometriosis * Informed consent EXCLUSION CRITERIA * Pregnancy * Pre-menarcheal or post-menopausal status * Chronic pelvic pain syndrome with or without central sensitization assessed with the Central Sensitization Inventory Test (CSI) * Neoplasia, diabetes, BMI \> 30 kg/m2, coagulopathies, autoimmune diseases, or other conditions that may affect salivary miRNA measurement * Currently undergoing progestin therapy
Where it's running
-
University of Udine
Udine, Ud, Italy Recruiting
Study contacts
- Study coordinator: Matilde Degano, dr
- Email: matildedegano@rocketmail.com
- Phone: 3206173076
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.